10 results on '"Misato Adachi"'
Search Results
2. Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients
- Author
-
Misato Adachi, Takeo Fukuchi, Hiroshi Matsuo, Noriyuki Sasaki, Tetsuya Togano, and Makoto Aihara
- Subjects
030213 general clinical medicine ,medicine.medical_specialty ,Time Factors ,Visual acuity ,genetic structures ,Combination therapy ,fixed combination ,Brinzolamide ,Thiazines ,Timolol ,Glaucoma ,Ocular hypertension ,Thiophenes ,intra‐ocular pressure ,Tonometry, Ocular ,03 medical and health sciences ,0302 clinical medicine ,Double-Blind Method ,Blurred vision ,Dorzolamide ,Ophthalmology ,Prostaglandins, Synthetic ,medicine ,Prospective Studies ,Intraocular Pressure ,Sulfonamides ,Dose-Response Relationship, Drug ,business.industry ,Original Articles ,General Medicine ,medicine.disease ,brinzolamide ,eye diseases ,Drug Combinations ,glaucoma ,Treatment Outcome ,dorzolamide ,030221 ophthalmology & optometry ,Original Article ,Ocular Hypertension ,sense organs ,Ophthalmic Solutions ,medicine.symptom ,business ,Glaucoma, Open-Angle ,Follow-Up Studies ,medicine.drug - Abstract
Purpose To compare the additive effects and safety of 1% brinzolamide/0.5% timolol fixed combination (BTFC) versus the low-dose regimen of 1% dorzolamide/0.5% timolol fixed combination (DTFC) in patients with open-angle glaucoma and ocular hypertension (OAG/OH) following treatment with prostaglandin analogues (PGAs). Methods A prospective, randomized, double-masked, multicentre, parallel-group and active-controlled study included 201 Japanese OAG/OH patients who had been treated with PGA. Efficacy was assessed as the change in intra-ocular pressure (IOP) from baseline after weeks 4 and 8. Safety was assessed with adverse event rates, ocular discomfort score, blur scale, blood pressure and heart rates, best-corrected visual acuity (BCVA) and slit lamp examinations. Results Intra-ocular pressure (IOP) change from baseline at 9 AM/11 AM pooled over the 8 weeks was −3.3/−3.3 mmHg in the BTFC group and −2.9/−3.4 mmHg in the DTFC group, demonstrating non-inferiority of BTFC to DTFC. Ocular irritation was frequently seen in DTFC group. Although blurred vision was frequently seen in BTFC group, it was transient and blurring became the equivalent 3 min after instillation between two groups. No noteworthy issue was observed in other safety outcome. Conclusion Non-inferiority of BTFC to DTFC in IOP reduction was demonstrated after adding onto PGA therapy in Japanese OAG/OH patients. Although the score of blurred vision was transiently higher in BTFC than DTFC, treatment difference decreased and disappeared with time. Thus, BTFC can be considered as a safe and effective agent for glaucoma treatment.
- Published
- 2017
- Full Text
- View/download PDF
3. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis
- Author
-
Tomoyuki Kakugawa, Hiroshi Mukae, Hanako Fujita, Yuji Ishimatsu, Noriho Sakamoto, Atsuko Hara, Misato Adachi, Shigeru Kohno, Shintaro Hara, and Shota Nakashima
- Subjects
Male ,Proteomics ,Pulmonary and Respiratory Medicine ,Pathology ,medicine.medical_specialty ,Neutrophils ,Enzyme-Linked Immunosorbent Assay ,Bronchoalveolar Lavage ,Sensitivity and Specificity ,S100A9 ,Diagnosis, Differential ,Leukocyte Count ,Idiopathic pulmonary fibrosis ,medicine ,Humans ,Calgranulin B ,Electrophoresis, Gel, Two-Dimensional ,In patient ,Idiopathic Interstitial Pneumonias ,Aged ,Lung ,medicine.diagnostic_test ,Receiver operating characteristic ,business.industry ,Bronchoalveolar lavage fluid ,Middle Aged ,respiratory system ,Prognosis ,medicine.disease ,Idiopathic Pulmonary Fibrosis ,respiratory tract diseases ,Bronchoalveolar lavage ,medicine.anatomical_structure ,Biomarker (medicine) ,Female ,Myeloid-related protein-14 ,Lung Diseases, Interstitial ,business ,Biomarkers ,Cryptogenic Organizing Pneumonia - Abstract
Summary Background Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic, progressive fibrosing interstitial pneumonia of unknown cause, and the prognosis remains poor. On the other hand, other fibrotic interstitial pneumonias such as idiopathic nonspecific interstitial pneumonia (I-NSIP) and collagen vascular disease-associated interstitial pneumonia (CVD-IP) resemble IPF, but they respond to therapy and the prognosis is better. We searched for biomarkers to distinguish IPF from other fibrotic interstitial pneumonias and investigated whether S100A9 could be useful for discriminating types of fibrotic interstitial pneumonia based on our preliminary proteomic findings. Methods We measured S100A9 levels in serum and bronchoalveolar lavage fluid (BALF) from 28 patients with IPF, 15 with I-NSIP, 20 with cryptogenic organizing pneumonia (COP), 35 with CVD-IP and 23 healthy individuals (controls) using enzyme-linked immunosorbent assays. S100A9 in the lung was also immunohistochemically localized. Results S100A9 levels in BALF, but not in serum, were significantly elevated in patients with IPF compared with I-NSIP, COP, CVD-IP and healthy individuals. S100A9 immunoreactivity was localized mainly in macrophages and neutrophils in lung specimens from patients with IPF. The results of receiver operating characteristic (ROC) curve analysis showed that BALF S100A9 levels had sufficient specificity and sensitivity to distinguish IPF from I-NSIP and CVD-IP. Conclusion S100A9 in BALF might serve as a candidate biomarker to discriminate between IPF and other fibrotic interstitial pneumonias.
- Published
- 2012
- Full Text
- View/download PDF
4. Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
- Author
-
Shinichiro Otani, Norihiko Honda, Naoki Hamada, Kazuhiko Unoki, Hiroshi Matsuo, Misato Adachi, Kazunori Miyata, Makoto Aihara, and Nobuyuki Koseki
- Subjects
Male ,Intraocular pressure ,genetic structures ,Side effect ,Manometry ,Ocular hypertension ,Glaucoma ,Timolol ,Prostaglandins, Synthetic ,medicine ,Humans ,Pharmacology (medical) ,Prospective Studies ,Antihypertensive Agents ,Intraocular Pressure ,Aged ,Pharmacology ,business.industry ,Brimonidine ,Middle Aged ,medicine.disease ,eye diseases ,Ophthalmology ,Blood pressure ,Prostaglandin analog ,Treatment Outcome ,Anesthesia ,Brimonidine Tartrate ,Drug Therapy, Combination ,Female ,Ocular Hypertension ,sense organs ,business ,Glaucoma, Open-Angle ,medicine.drug ,Follow-Up Studies - Abstract
To assess the efficacy and safety of switching from timolol 0.5% to brimonidine 0.1% in patients with glaucoma treated with a prostaglandin analog (PGA) and timolol combination.This prospective, open-label multicenter study enrolled patients with open-angle glaucoma or ocular hypertension who were being treated with a PGA and timolol. After baseline measurements, timolol was switched to brimonidine 0.1%, and patients were followed for 12 weeks. Patients visited at 4 and 12 weeks after switching. The main outcome measure was the change in intraocular pressure (IOP). For safety evaluations, hyperemia, formation of conjunctival follicles, superficial punctate keratopathy as a local side effect, blood pressure (BP), and heart rate (HR) were evaluated.One hundred seven patients participated in this study. Among them, 103 patients completed the study. The IOP values at baseline, 4 weeks, and 12 weeks after the transition were 15.7 ± 2.7, 14.3 ± 2.8, and 14.0 ± 2.8 mmHg, respectively. IOP was significantly reduced at 4 and 12 weeks compared with baseline (p0.001). There were no significant changes in hyperemia or follicle formation. The superficial punctate keratopathy score was significantly reduced at 12 weeks compared with baseline (p0.05). Systolic and diastolic BP values were significantly reduced and HR significantly increased after switching (p0.05).Switching from timolol 0.5% to brimonidine 0.1% may not change IOP in the combination use of timolol 0.5% and a PGA and was well tolerated by patients without severe ocular or systemic side effects.
- Published
- 2015
5. Filtering Bleb Modification With a THC:YAG (Holmium) Laser
- Author
-
Maria F Delgado, Motryja Makarewycz, Patricia C. Wong, Misato Adachi, Andrew G. Iwach, and Ngoc Tinh Nguyen
- Subjects
Leak ,medicine.medical_specialty ,Intraocular pressure ,Visual acuity ,genetic structures ,business.industry ,Eye disease ,medicine.medical_treatment ,medicine.disease ,eye diseases ,Surgery ,Suction blister ,surgical procedures, operative ,Ophthalmology ,Glaucoma surgery ,Medicine ,sense organs ,Bleb (cell biology) ,medicine.symptom ,business ,Hyphema - Abstract
* OBJECTIVE: To present a method for remodeling oversized blebs using the THC: YAG laser and describe its use in treating hypotony and bleb leaks. * METHODS: Retrospective medical record review of 13 patients who underwent holmium laser bleb revision. * RESULTS: Thirteen eyes of 13 patients were analyzed. All the patients had an oversized bleb and 2 patients presented an associated late-onset leaking bleb. Mean preoperative IOP was 4.1 mm Hg. THCYAG laser energy was applied to the bleb to remodel and/or close the leak. After a mean follow up of 17.3 months, the mean IOP was 7.84 mm Hg ± 2.3. Postsurgery complications included hyphema and the inadvertent rupture of a conjunctival microcyst. Visual acuity improved in 9 of the eyes and remained stable in 4 of the eyes. * CONCLUSION: The THCYAG laser can be used effectively to sculpt large blebs, reduce symptoms associated with large blebs, increase IOP in hypotonous eyes, and under specific circumstances, close bleb leaks. [Ophthalmic Surg Lasers 2002;33:181-187]
- Published
- 2002
- Full Text
- View/download PDF
6. Colonic hydrogen generated from fructan diffuses into the abdominal cavity and reduces adipose mRNA abundance of cytokines in rats
- Author
-
Misato Adachi, Naomichi Nishimura, Hiroki Tanabe, Michihiro Fukushima, and Tatsuro Yamamoto
- Subjects
Male ,medicine.medical_specialty ,Colon ,Inulin ,Medicine (miscellaneous) ,Adipose tissue ,Abdominal cavity ,Biology ,medicine.disease_cause ,Real-Time Polymerase Chain Reaction ,Proinflammatory cytokine ,Excretion ,Rats, Sprague-Dawley ,chemistry.chemical_compound ,Internal medicine ,medicine ,Animals ,RNA, Messenger ,Nutrition and Dietetics ,Fructooligosaccharide ,Area under the curve ,Abdominal Cavity ,Fructans ,Rats ,medicine.anatomical_structure ,Endocrinology ,chemistry ,Biochemistry ,Adipose Tissue ,Cytokines ,Oxidative stress ,Hydrogen - Abstract
Hydrogen (H2) protects against inflammation-induced oxidative stress. Nondigestible saccharides (NDSs) enhance colonic H2 production. We examined whether colonic H2 transfers to tissues in the abdominal cavity and whether it affects expression of proinflammatory cytokines. In Expts. 1 and 2, rats were fed diets containing fructooligosaccharides [FOSs; 25 (Expt. 1) and 50 g/kg (Expts. 1 and 2)] for 7 and 14 d, respectively. The no-FOS diet was used as the control diet. At the end of the experiment, H2 excretion and the portal H2 concentration were significantly greater in the FOS group than in the control group. In the FOS group, the arterial H2 concentration was no more than 1.5% of the portal H2 concentration (P = 0.03). The H2 concentration in abdominal cavity tissues, especially adipose tissue, in the FOS group was 5.6- to 43-fold of that in the control group (P < 0.05). The H2 content in the abdominal cavity in the FOS group was 11-fold of that in the control group (P < 0.05). In Expt. 3, rats were fed a high-fat diet containing FOS and inulin (50 g/kg) for 28 d. The area under the curve for H2 excretion between 0 and 28 d and portal and adipose H2 concentrations were significantly higher in the FOS and inulin groups than in the high-fat control group. Adipose mRNA abundance of nuclear factor kappa-light-chain-enhancer of activated B cells 1 was lower in the FOS group than in the control group (P = 0.02) and those of interleukin-6 and chemokine (C-C motif) ligand 2 tended to be lower (P < 0.11). Colonic H2 generated from NDS diffuses to the abdominal cavity before transferring to abdominal tissues. Reduced cytokine expression by FOS feeding might be dependent on increased colonic H2. Colonic H2 may have important implications in the suppressive effect on metabolic syndrome via oxidative stress.
- Published
- 2013
7. Filtering bleb modification with a THC:YAG (Holmium) laser
- Author
-
Andrew G, Iwach, Maria E, Delgado, Misato, Adachi, Motryja, Makarewycz, Patricia, Wong, and Ngoc, Nguyen
- Subjects
Adult ,Aged, 80 and over ,Male ,Visual Acuity ,Glaucoma ,Middle Aged ,Holmium ,Filtering Surgery ,Humans ,Female ,Laser Therapy ,Intraocular Pressure ,Aged ,Retrospective Studies - Abstract
To present a method for remodeling oversized blebs using the THC:YAG laser and describe its use in treating hypotony and bleb leaks.Retrospective medical record review of 13 patients who underwent holmium laser bleb revision.Thirteen eyes of 13 patients were analyzed. All the patients had an oversized bleb and 2 patients presented an associated late-onset leaking bleb. Mean preoperative IOP was 4.1 mm Hg. THC:YAG laser energy was applied to the bleb to remodel and/or close the leak. After a mean follow up of 17.3 months, the mean IOP was 7.84 mm Hg +/- 2.3. Postsurgery complications included hyphema and the inadvertent rupture of a conjunctival microcyst. Visual acuity improved in 9 of the eyes and remained stable in 4 of the eyes.The THC:YAG laser can be used effectively to sculpt large blebs, reduce symptoms associated with large blebs, increase IOP in hypotonous eyes, and under specific circumstances, close bleb leaks.
- Published
- 2002
8. Risk factors for the progression of treated primary open-angle glaucoma: a multivariate life-table analysis
- Author
-
Yoko Suzuki, Chikuma Hamada, Misato Adachi, and Shiroaki Shirato
- Subjects
Male ,medicine.medical_specialty ,Intraocular pressure ,genetic structures ,Open angle glaucoma ,Eye disease ,Glaucoma ,Refraction, Ocular ,Cellular and Molecular Neuroscience ,Sex Factors ,Risk Factors ,Ophthalmology ,medicine ,Humans ,Stage (cooking) ,Risk factor ,Intraocular Pressure ,Proportional Hazards Models ,Retrospective Studies ,Proportional hazards model ,business.industry ,Age Factors ,Middle Aged ,medicine.disease ,Prognosis ,eye diseases ,Sensory Systems ,Surgery ,Visual field ,Multivariate Analysis ,Disease Progression ,Female ,sense organs ,business ,Glaucoma, Open-Angle ,Follow-Up Studies - Abstract
· Background: Several factors have been reported as risk factors for the progression of primary open-angle glaucoma (POAG) but previous reports were not necessarily in agreement. We applied a multivariate life-table analysis to a large number of longitudinal data to determine the extent of the influence of various factors simultaneously. · Methods: Two hundred fifteen eyes of 215 POAG patients were included. The follow-up period ranged from 24 to 134 months (average 82.7 months). The visual field stage was determined separately in upper and lower hemifields according to the classification of Aulhorn (modified by Greve). The progression was defined as an irreversible increase of the stage in at least one hemifield. The follow-up data were analyzed with the Cox proportional hazard model. · Results: Mean intraocular pressure (IOP) in the follow-up period and the initial visual field stage significantly affected POAG progression (P
- Published
- 1999
9. Clinical experience of trabeculotomy for the surgical treatment of aniridic glaucoma
- Author
-
Andrew G. Iwach, Albert S. Ma, Patricia C. Wong, Christopher J. Dickens, H. Dunbar Hoskins, Ngoc Tinh Nguyen, Misato Adachi, and John Hetherington
- Subjects
Adult ,medicine.medical_specialty ,Intraocular pressure ,Visual acuity ,genetic structures ,Adolescent ,Eye disease ,medicine.medical_treatment ,Visual Acuity ,Glaucoma ,Trabeculectomy ,Ophthalmology ,medicine ,Glaucoma surgery ,Humans ,Child ,Aniridia ,Intraocular Pressure ,business.industry ,Infant, Newborn ,Infant ,medicine.disease ,Trabeculotomy ,eye diseases ,Surgery ,Treatment Outcome ,Child, Preschool ,sense organs ,medicine.symptom ,business ,Molteno Implants ,Follow-Up Studies - Abstract
Objective: The purpose of this study is to determine the efficacy of initial trabeculotomy in the patient with aniridic glaucoma. Design: Clinical charts were reviewed. Participants: Twenty-nine eyes of 16 patients with aniridia were studied. Intervention: Glaucoma surgery was performed. As an initial procedure, trabeculotomy was performed in 12 eyes, other surgery was performed in 17 eyes (trabeculectomy, 5; goniotomy, 5; other, 7). Main Outcome Measures: Success was defined as an intraocular pressure (lOP) of 21 mmHg or lower, and no further surgery was performed. Results: Ten (83%) of 12 eyes obtained lOP control after first (6 eyes) or second (4 eyes) trabeculotomy with a mean follow-up period of 9.5 years. Five eyes maintained visual acuity of 20/40 to 20/200. No serious complications were found after trabeculotomy. Three (18%) of 17 eyes were controlled with the first glaucoma surgery other than trabeculotomy (goniotomy, trabeculectomy, trabeculectomy combined with trabeculotomy, and Molteno implant). Good lOP control was obtained in 8 (47%) of 17 eyes after several surgeries with a mean follow-up period of 10.4 years. Four of 17 eyes became phthisical. Conclusion: This study suggests that trabeculotomy is the preferred initial operation for uncontrolled glaucoma with aniridia.
- Published
- 1997
10. Human chorionic gonadotropin in normal, inflammatory, and carcinomatous gastric tissue
- Author
-
Misato Adachi, Kazuhiro Hirao, and Toshiaki Manabe
- Subjects
Adult ,Gastritis, Atrophic ,Male ,endocrine system ,medicine.medical_specialty ,Pathology ,Adenocarcinoma ,Biology ,Chorionic Gonadotropin ,Human chorionic gonadotropin ,Immunoenzyme Techniques ,Stomach Neoplasms ,Internal medicine ,medicine ,Gastric mucosa ,Carcinoma ,Humans ,Chorionic Gonadotropin, beta Subunit, Human ,Stomach Ulcer ,reproductive and urinary physiology ,Aged ,Hepatology ,Histocytochemistry ,Stomach ,digestive, oral, and skin physiology ,Gastroenterology ,Cancer ,Middle Aged ,medicine.disease ,Pylorus ,Adenocarcinoma, Mucinous ,Peptide Fragments ,digestive system diseases ,medicine.anatomical_structure ,Endocrinology ,Gastric Mucosa ,embryonic structures ,Carcinoma, Squamous Cell ,Female ,Gastritis ,medicine.symptom - Abstract
Tissues from 12 patients with gastric ulcers, 50 patients with gastric carcinoma, and 2 normal subjects who died suddenly were examined immunohistochemically with antiserum against the beta-subunit of human chorionic gonadotropin. Human chorionic gonadotropin-beta-immunoreactive cells were present in the neck portion of the pyloric and pseudopyloric glands of normal and inflammatory gastric tissue. Gastric cancers located in the antrum-pylorus and the cardia were frequently associated with human chorionic gonadotropin immunoreactivity. These findings indicate that human chorionic gonadotropin-producing cells normally exist in the gastric mucosa, especially in the pylorus. It is speculated that normal human chorionic gonadotropin-producing cells may give rise to cancer in certain cases.
- Published
- 1985
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.